Concepedia

Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy

Shino Sato, Kazuyuki Hirooka, Eri Nitta, Kaori Ukegawa, Akitaka Tsujikawa

Advances in Therapy · 2016 · 35 citations · 9 references

DOI

Concepts

References

9

The Ocular Hypertension Treatment Study

Michael A. Kass · Archives of Ophthalmology · 2002 · 3.7K citations · Full text

, , +14

Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.

Megumi Honjo, Hidenobu Tanihara, Masaru Inatani et al. · PubMed · 2001 · 390 citations

, , +14

Phase 2 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension

Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · American Journal of Ophthalmology · 2013 · 190 citations

, , +12

Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and Monkeys

Hideki Tokushige, Masaru Inatani, Shingo Nemoto et al. · Investigative Ophthalmology & Visual Science · 2007 · 175 citations

, , +13

One‐year clinical evaluation of 0.4% ripasudil (K‐115) in patients with open‐angle glaucoma and ocular hypertension

Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · Acta Ophthalmologica · 2015 · 135 citations · Full text

, , +15